InvestorsHub Logo
Followers 117
Posts 20170
Boards Moderated 0
Alias Born 06/13/2011

Re: None

Monday, 03/13/2023 11:36:07 AM

Monday, March 13, 2023 11:36:07 AM

Post# of 35
Buying at these levels . Their LN program looks to be kicking into gear . Update on Wed.
.

We are progressing more quickly than planned with initiating PALIZADE, our next study of zetomipzomib for the treatment of lupus nephritis, and look forward to sharing the details," said John Fowler, Kezar’s Co-founder and Chief Executive Office


Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KZR News